FindTrial
Sign In

Screening of early diagnostic markers for acute kidney injury and clinical application of early warning and prediction models

Screening of early diagnostic markers for acute kidney injury and clinical application of early warning and prediction models

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048594
Enrollment
Unknown
Registered
2021-07-11
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Interventions

Gold Standard:Diagnostic criteria for acute kidney injury using the KDIGO guidelines or pathological biopsy of the kidney
Index test:Serum&#32
creatinine&#32
and&#32
acute&#32
kidney&#32
injury&#32
early&#32
markers&#32
(Kim-1,&#32
NAGAL)

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Voluntary participation, provide written informed consent; gender is not limited, aged 18 to 70 years; basic renal function is normal; AKI high-risk group; can comply with the research or follow-up procedures.

Exclusion criteria

Exclusion criteria: Chronic kidney disease (CKD); patients with end-stage renal disease (eGFR<30 ml/min/1.73m2); patients with mental disorders; those who are considered inappropriate by the investigator to participate in this trial.

Design outcomes

Primary

MeasureTime frame
serum creatinine concentration;AUC of ROC, SEN, SPE, ACC;—

Countries

China

Contacts

Public ContactYang Xiangdong

Qilu Hospital of Shandong University

yxd683@163.com+86 18560083856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026